Cite
HARVARD Citation
Zhang, C. et al. (2021). Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies. Journal for immunotherapy of cancer. 9 (7), p. . [Online].